EFFICACY OF BRIVARACETAM IN PEDIATRIC EPILEPSY: AN UP-TO-DATE
Among the newest antiepileptic drugs, brivaracetam (BRV), previously known as “ucb34714”, is one of the most interesting molecules available, increasingly getting the attention of researchers. The clinical efficacy of BRV as adjunctive therapy has been extensively assessed in six randomized, control...
Saved in:
Main Author: | Antonio Nicotera |
---|---|
Format: | article |
Language: | EN |
Published: |
Associazione Italiana Giovani Medici
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/8a459c6dc1de4afab53dabd6fdeebd23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A review of the pharmacology and clinical efficacy of brivaracetam
by: Klein P, et al.
Published: (2018) -
Brivaracetam in the treatment of epilepsy: a review of clinical trial data
by: Feyissa AM
Published: (2019) -
Overnight switch from levetiracetam to brivaracetam. Safety and tolerability
by: L. Abraira, et al.
Published: (2021) -
Effects of 12-month Antiepileptic Drug Use on Thyroid Functions in Children: A Retrospective Observational Study
by: Fatma Hancı, et al.
Published: (2021) -
Plasma Homocysteine Level in Children under Treatment with Antiepileptic Drugs and its Relation to Intelligence Quotient
by: Mohammed Abo Al-maaty, et al.
Published: (2020)